Atlas Trials

Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine

Clinical trial NCT05166031 · WITHDRAWN

Trial details

NCT number
NCT05166031
Sponsor
Fidec Corporation
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Poliomyelitis
Start date
2020-12-01
Primary completion
2021-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.